The effect of the number of fractions of cranial irradiation on growth in children with acute lymphoblastic leukaemia.

J H Brämswig, M Wegele, H J von Lengerke, R P Müller, G Schellong
{"title":"The effect of the number of fractions of cranial irradiation on growth in children with acute lymphoblastic leukaemia.","authors":"J H Brämswig,&nbsp;M Wegele,&nbsp;H J von Lengerke,&nbsp;R P Müller,&nbsp;G Schellong","doi":"10.1111/j.1651-2227.1989.tb11073.x","DOIUrl":null,"url":null,"abstract":"<p><p>Growth was documented over a period of 7 years in all long-term survivors treated for acute lymphoblastic leukaemia (ALL) with the DAL-70- (n = 15) and BFM-70-protocol (n = 27). Normal growth was documented in patients of the DAL-70-protocol during and after therapy. In contrast, in children treated with the BFM-70-protocol the mean height standard deviation score (SDS) decreased significantly from 1.21 SDS prior to therapy to 0.80 SDS at the end of therapy (p less than 0.001) and remained unchanged thereafter. Prophylactic cranial irradiation was given in total doses of 15 to 30 Gy. Ten children of the DAL-70- and 20 children of the BFM-70-protocol received 24 Gy of cranial irradiation. No significant change in height-SDS was observed in any patients of the DAL-70- and in 8 patients of the BFM-70- group, who received 24 Gy of cranial irradiation in 16-26 fractions. Adult height in 7 girls and 6 boys was normal and 3.15 cm and 5.06 cm above target height. In the remaining 12 patients of the BFM-70-protocol the total dose of 24 Gy of cranial irradiation was applied in 11-14 fractions. Their height-SDS had fallen significantly from 1.24 SDS before to 0.66 SDS (p less than 0.001) at the end of therapy. Adult height in 4 girls and 6 boys was also normal, but the height increase was comparatively smaller, -2.20 cm below target height in the girls and 1.91 cm above in the boys.(ABSTRACT TRUNCATED AT 250 WORDS)</p>","PeriodicalId":75407,"journal":{"name":"Acta paediatrica Scandinavica","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"1989-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1111/j.1651-2227.1989.tb11073.x","citationCount":"20","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Acta paediatrica Scandinavica","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1111/j.1651-2227.1989.tb11073.x","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 20

Abstract

Growth was documented over a period of 7 years in all long-term survivors treated for acute lymphoblastic leukaemia (ALL) with the DAL-70- (n = 15) and BFM-70-protocol (n = 27). Normal growth was documented in patients of the DAL-70-protocol during and after therapy. In contrast, in children treated with the BFM-70-protocol the mean height standard deviation score (SDS) decreased significantly from 1.21 SDS prior to therapy to 0.80 SDS at the end of therapy (p less than 0.001) and remained unchanged thereafter. Prophylactic cranial irradiation was given in total doses of 15 to 30 Gy. Ten children of the DAL-70- and 20 children of the BFM-70-protocol received 24 Gy of cranial irradiation. No significant change in height-SDS was observed in any patients of the DAL-70- and in 8 patients of the BFM-70- group, who received 24 Gy of cranial irradiation in 16-26 fractions. Adult height in 7 girls and 6 boys was normal and 3.15 cm and 5.06 cm above target height. In the remaining 12 patients of the BFM-70-protocol the total dose of 24 Gy of cranial irradiation was applied in 11-14 fractions. Their height-SDS had fallen significantly from 1.24 SDS before to 0.66 SDS (p less than 0.001) at the end of therapy. Adult height in 4 girls and 6 boys was also normal, but the height increase was comparatively smaller, -2.20 cm below target height in the girls and 1.91 cm above in the boys.(ABSTRACT TRUNCATED AT 250 WORDS)

头颅照射次数对急性淋巴细胞白血病患儿生长的影响。
在所有接受DAL-70- (n = 15)和bfm -70方案(n = 27)治疗的急性淋巴细胞白血病(all)的长期幸存者中,生长记录超过7年。dal -70方案的患者在治疗期间和治疗后均记录了正常的生长。相比之下,在接受bfm -70方案治疗的儿童中,平均身高标准差(SDS)从治疗前的1.21 SDS显著下降到治疗结束时的0.80 SDS (p < 0.001),此后保持不变。预防性颅脑照射总剂量为15 ~ 30 Gy。DAL-70方案的10名儿童和bfm -70方案的20名儿童接受了24 Gy的颅脑照射。DAL-70-组和BFM-70-组均接受16-26次24 Gy颅脑照射,8例患者的身高- sds无明显变化。7名女生和6名男生成人身高正常,分别高出目标身高3.15 cm和5.06 cm。在其余12例bfm -70方案患者中,总剂量为24 Gy的颅骨照射按11-14次进行。他们的身高SDS从治疗前的1.24 SDS显著下降到治疗结束时的0.66 SDS (p < 0.001)。4名女生和6名男生成人身高也正常,但身高增幅相对较小,女生比目标身高低-2.20 cm,男生比目标身高高1.91 cm。(摘要删节250字)
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信